Table of Contents Author Guidelines Submit a Manuscript
International Journal of Nephrology
Volume 2012, Article ID 170857, 10 pages
http://dx.doi.org/10.1155/2012/170857
Review Article

Minimizing Hemodialysis Catheter Dysfunction: An Ounce of Prevention

1University of Cincinnati, Cincinnati, OH 45267-0585, USA
2Faculty of Medicine, University of Toronto, University Health Network-Toronto General Hospital, Toronto, ON, Canada M5G 2C4
3University of Texas Southwestern Medical Center, Dallas, TX 75390-8856, USA
4Department of Epidemiology and Biostatistics, University of Western Ontario, London, ON, Canada N6A 5W9
5Division of Nephrology, Department of Medicine, University of Western Ontario, London, ON, Canada N6A 5W9
6Nephrology Associates of Central Florida, Lake Mary, FL 32746, USA
7Albert Einstein College of Medicine, Bronx, NY 10467, USA

Received 29 September 2011; Accepted 10 October 2011

Academic Editor: Alexander Yevzlin

Copyright © 2012 Timmy Lee et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. National Kidney Foundation DOQI, “Clinical practice guidelines for vascular access,” American Journal of Kidney Diseases, vol. 48, supplement 1, pp. S176–S247, 2006. View at Google Scholar
  2. US Renal Data System, USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States, National Institutes of Health NIDDK, Bethesda, Md, USA, 2010.
  3. A. Besarab and R. Pandey, “Catheter management in HD patients: delivering adequate flow,” Clinical Journal of the American Society of Nephrology, vol. 6, no. 1, pp. 227–234, 2011. View at Google Scholar
  4. A. Asif, D. Merrill, P. Briones, D. Roth, and G. A. Beathard, “Hemodialysis vascular access: percutaneous interventions by nephrologists,” Seminars in Dialysis, vol. 17, no. 6, pp. 528–534, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. E. Lacson, J. M. Lazarus, J. Himmelfarb, T. A. Ikizler, and R. M. Hakim, “Balancing fistula first with catheters last,” American Journal of Kidney Diseases, vol. 50, no. 3, pp. 379–395, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. J. Davidson, P. Arnold, and F. Rivera, “Dual lumen catheters for dialysis,” in Access for Dialysis, J. Davidson, Ed., Landes Bioscience, Georgetown, Ky, USA, 2002. View at Google Scholar
  7. C. M. Thomas, J. Zhang, T. H. Lim, N. Scott-Douglas, R. B. Hons, and B. R. Hemmelgam, “Alberta kidney disease network. Concentration of heparin-locking solution and risk of central venous HD catheter malfunction,” ASAIO Journal, vol. 53, pp. 485–488, 2007. View at Google Scholar
  8. J. L. Holley and S. Bailey, “Catheter lock heparin concentration: effects on tissue plasminogen activator use in tunneled cuffed catheters,” Hemodialysis International, vol. 11, no. 1, pp. 96–98, 2007. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Buturovic, R. Ponikvar, A. Kandus, M. Boh, J. Klinkmann, and P. Ivanovitch, “Filling HD catheters in the interdialytic period: heparin versus citrate versus polygeline: a prospective randomized study,” Artificial Organs, vol. 22, pp. 945–947, 1998. View at Google Scholar
  10. C. E. Lok, D. Appleton, C. Bhola, B. Khoo, and R. M. A. Richardson, “Trisodium citrate 4%—an alternative to heparin capping of haemodialysis catheters,” Nephrology Dialysis Transplantation, vol. 22, no. 2, pp. 477–483, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Grudzinski, P. Quinan, S. Kwok, and A. Pierratos, “Sodium citrate 4% locking solution for central venous dialysis catheters—an effective, more cost-efficient alternative to heparin,” Nephrology Dialysis Transplantation, vol. 22, no. 2, pp. 471–476, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. J. M. MacRae, I. Dojcinovic, O. Djurdjev et al., “Citrate 4% versus heparin and the reduction of thrombosis study (CHARTS),” Clinical Journal of the American Society of Nephrology, vol. 3, no. 2, pp. 369–374, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Hendrickx, D. Kuypers, P. Evenepoel, B. Maes, T. Messiaen, and Y. Vanrenterghem, “A comparative prospective study on the use of low concentrate citrate lock versus heparin lock in permanent dialysis catheters,” International Journal of Artificial Organs, vol. 24, no. 4, pp. 208–211, 2001. View at Google Scholar · View at Scopus
  14. K. J. F. Stas, J. Vanwalleghem, B. De Moor, and H. Keuleers, “Trisodium citrate 30% vs heparin 5% as catheter lock in the interdialytic period in twin- or double-lumen dialysis catheters for intermittent haemodialysis,” Nephrology Dialysis Transplantation, vol. 16, no. 7, pp. 1521–1522, 2001. View at Google Scholar · View at Scopus
  15. M. C. Wiejmer, M. A. van den Dorpel, P. J. G. Van de Ven et al., “Randomized, clinical trial comparison of trisodium citrate 30% and heparin as catheter-locking solution in HD patients,” Journal of the American Society of Nephrology, vol. 16, pp. 2769–2777, 2005. View at Google Scholar
  16. B. Bayes, J. Bonal, and R. Romero, “Sodium citrate for filling haemodialysis catheters,” Nephrology Dialysis Transplantation, vol. 14, no. 10, pp. 2532–2533, 1999. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Power, N. Duncan, S. K. Singh et al., “Sodium citrate versus heparin catheter locks for cuffed central venous catheters: a single-center randomized controlled trial,” American Journal of Kidney Diseases, vol. 53, no. 6, pp. 1034–1041, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Schenk, A. R. Rosenkranz, G. Wölfl, W. H. Hörl, and O. Traindl, “Recombinant tissue plasminogen activator is a useful alternative to heparin in priming Quinton Permcath,” American Journal of Kidney Diseases, vol. 35, no. 1, pp. 130–136, 2000. View at Google Scholar · View at Scopus
  19. N. S. Gittins, Y. L. Hunter-Blair, J. N. S. Matthews, and M. G. Coulthard, “Comparison of alteplase and heparin in maintaining the patency of paediatric central venous haemodialysis lines: a randomised controlled trial,” Archives of Disease in Childhood, vol. 92, no. 6, pp. 499–501, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. B. R. Hemmelgarn, L. M. Moist, C. E. Lok et al., “Prevention of dialysis catheter malfunction with recombinant tissue plasminogen activator,” The New England Journal of Medicine, vol. 364, pp. 303–312, 2011. View at Google Scholar
  21. T. W. I Clark, D. Jacobs, H. W. Charles et al., “Comparison of heparin-coated and conventional split-tip HD catheters,” CardioVascular and Interventional Radiology, vol. 32, pp. 703–706, 2009. View at Google Scholar
  22. G. Jain, M. Allon, S. Saddekni, J. Barker-Finkel, and I. D. Maya, “Does heparin coating improve patency or reduce infection of tunneled dialysis catheters?” Clinical Journal of the American Society of Nephrology, vol. 4, no. 11, pp. 1787–1790, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. M. H. Mokrzycki, K. Jean-Jerome, H. Rush, M. P. Zdunek, and S. O. Rosenberg, “A randomized trial of minidose warfarin for the prevention of late malfunction in tunneled, cuffed hemodialysis catheters,” Kidney International, vol. 59, no. 5, pp. 1935–1942, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. T. J. Wilkieson, A. J. Ingram, M. A. Crowther et al., “Low-intensity adjusted-dose warfarin for the prevention of HD catheter failure: a randomized controlled trial,” Clinical Journal of the American Society of Nephrology, vol. 6, pp. 1018–1024, 2011. View at Google Scholar
  25. M. Zellweger, J. Bouchard, S. Raymond-Carrier, A. Laforest-Renald, S. Quérin, and F. Madore, “Systemic anticoagulation and prevention of hemodialysis catheter malfunction,” ASAIO Journal, vol. 51, no. 4, pp. 360–365, 2005. View at Publisher · View at Google Scholar · View at Scopus
  26. C. I. Obialo, A. C. Conner, and L. F. Lebon, “Maintaining patency of tunneled hemodialysis catheters—efficacy of aspirin compared to warfarin,” Scandinavian Journal of Urology and Nephrology, vol. 37, no. 2, pp. 172–176, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. L. Colì, G. Donati, G. Cianciolo et al., “Anticoagulation therapy for the prevention of hemodialysis tunneled cuffed catheter (TCC) thrombosis,” Journal of Vascular Access, vol. 7, no. 3, pp. 118–122, 2006. View at Google Scholar · View at Scopus
  28. J. Work, “Chronic catheter placement,” Seminars in Dialysis, vol. 14, no. 6, pp. 436–440, 2001. View at Google Scholar · View at Scopus
  29. P. A. Conz, D. Dissegna, M. P. Rodighiero, and G. La Greca, “Cannulation of the internal jugular vein: comparison of the classic Seldinger technique and an ultrasound guided method,” Journal of Nephrology, vol. 10, no. 6, pp. 311–313, 1997. View at Google Scholar · View at Scopus
  30. R. Vanholder and S. Ringoir, “Vascular access for HD,” American Journal of Kidney Diseases, vol. 25, pp. 732–737, 1995. View at Google Scholar
  31. J. S. Lameris, P. J. M. Post, H. M. Zonderland, P. G. Gerritsen, M. C. Kappers-Klunne, and H. E. Schutte, “Percutaneous placement of Hickman catheters: comparison of sonographically guided and blind techniques,” American Journal of Roentgenology, vol. 155, no. 5, pp. 1097–1099, 1990. View at Google Scholar · View at Scopus
  32. A. R. Forauer and J. F. Glockner, “Importance of US findings in access planning during jugular vein hemodialysis catheter placements,” Journal of Vascular and Interventional Radiology, vol. 11, no. 2, part 1, pp. 233–238, 2000. View at Google Scholar · View at Scopus
  33. S. J. Schwab, L. D. Quarles, J. P. Middleton, R. H. Cohan, M. Saeed, and V. W. Dennis, “Hemodialysis-associated subclavian vein stenosis,” Kidney International, vol. 33, no. 6, pp. 1156–1159, 1988. View at Google Scholar · View at Scopus
  34. R. M. Donlan and J. W. Costerton, “Biofilms: survival mechanisms of clinically relevant microorganisms,” Clinical Microbiology Reviews, vol. 15, no. 2, pp. 167–193, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. J. W. Costerton, P. S. Stewart, and E. P. Greenberg, “Bacterial biofilms: a common cause of persistent infections,” Science, vol. 284, no. 5418, pp. 1318–1322, 1999. View at Publisher · View at Google Scholar · View at Scopus
  36. J. W. Costerton, K. J. Cheng, G. G. Geesey et al., “Bacterial biofilms in nature and disease,” Annual Review of Microbiology, vol. 41, pp. 435–464, 1987. View at Google Scholar · View at Scopus
  37. M. K. Dasgupta, “Biofilms and infection in dialysis patients,” Seminars in Dialysis, vol. 15, no. 5, pp. 338–346, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. L. Passerini, K. Lam, J. W. Costerton, and E. G. King, “Biofilms on indwelling vascular catheters,” Critical Care Medicine, vol. 20, no. 5, pp. 665–673, 1992. View at Google Scholar · View at Scopus
  39. E. Anaissie, G. Samonis, D. Kontoyiannis et al., “Role of catheter colonization and infrequent hematogenous seeding in catheter-related infections,” European Journal of Clinical Microbiology and Infectious Diseases, vol. 14, no. 2, pp. 134–137, 1995. View at Publisher · View at Google Scholar · View at Scopus
  40. I. Raad, W. Costerton, U. Sabharwal, M. Sacilowski, E. Anaissie, and G. P. Bodey, “Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement,” Journal of Infectious Diseases, vol. 168, no. 2, pp. 400–407, 1993. View at Google Scholar · View at Scopus
  41. A. Dwyer, “Surface-treated catheters—a review,” Seminars in Dialysis, vol. 21, no. 6, pp. 542–546, 2008. View at Publisher · View at Google Scholar · View at Scopus
  42. S. Faintuch and G. M. M. Salazar, “Malfunction of dialysis catheters: management of fibrin sheath and related problems,” Techniques in Vascular and Interventional Radiology, vol. 11, no. 3, pp. 195–200, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. J. R. Mehall, D. A. Saltzman, R. J. Jackson, and S. D. Smith, “Fibrin sheath enhances central venous catheter infection,” Critical Care Medicine, vol. 30, no. 4, pp. 908–912, 2002. View at Google Scholar · View at Scopus
  44. O. Liangos, A. Gul, N. E. Madias, and B. L. Jaber, “Long-term management of the tunneled venous catheter,” Seminars in Dialysis, vol. 19, no. 2, pp. 158–164, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. H. Ishida, Y. Ishida, Y. Kurosaka, T. Otani, K. Sato, and H. Kobayashi, “In vitro and in vivo activities of levofloxacin against biofilm- producing Pseudomonas aeruginosa,” Antimicrobial Agents and Chemotherapy, vol. 42, no. 7, pp. 1641–1645, 1998. View at Google Scholar · View at Scopus
  46. J. W. Bosma, C. E. Siegert, P. G. Peerbooms, and M. C. Weijmer, “Reduction of biofilm formation with trisodium citrate in haemodialysis catheters: a randomized controlled trial,” Nephrology, Dialysis, Transplantation, vol. 25, pp. 1213–1217, 2010. View at Google Scholar
  47. S. M. Jones, P. Ravani, B. R. Hemmelgarn, D. Muruve, and J. M. Macrae, “Morphometric and biological characterization of biofilm in tunneled HD catheters,” American Journal of Kidney Diseases, vol. 57, pp. 449–455, 2011. View at Google Scholar
  48. A. S. Yevzlin, R. J. Sanchez, J. G. Hiatt et al., “Concentrated heparin lock is associated with major bleeding complications after tunneled hemodialysis catheter placement,” Seminars in Dialysis, vol. 20, no. 4, pp. 351–354, 2007. View at Publisher · View at Google Scholar · View at Scopus
  49. M. Sungur, E. Eryuksel, S. Yavas, A. Bihorac, A. J. Layon, and L. Caruso, “Exit of catheter lock solutions from double lumen acute haemodialysis catheters—an in vitro study,” Nephrology Dialysis Transplantation, vol. 22, no. 12, pp. 3533–3537, 2007. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Agharazii, I. Plamondon, M. Lebel, P. Douville, and S. Desmeules, “Estimation of heparin leak into the systemic circulation after central venous catheter heparin lock,” Nephrology Dialysis Transplantation, vol. 20, pp. 1238–1240, 2005. View at Publisher · View at Google Scholar · View at Scopus
  51. I. Markota, D. Markota, and M. Tomic, “Measuring of the heparin leakage into the circulation from central venous catheters—an in vivo study,” Nephrology Dialysis Transplantation, vol. 24, no. 5, pp. 1550–1553, 2009. View at Publisher · View at Google Scholar · View at Scopus
  52. H. D. Polaschegg and C. Shah, “Overspill of catheter locking solution: safety and efficacy aspects,” ASAIO Journal, vol. 49, no. 6, pp. 713–715, 2003. View at Publisher · View at Google Scholar · View at Scopus
  53. H. Karaaslan, P. Peyronnet, D. Benevent, C. Lagarde, M. Rince, and C. Leroux-Robert, “Risk of heparin lock-related bleeding when using indwelling venous catheter in haemodialysis,” Nephrology Dialysis Transplantation, vol. 16, no. 10, pp. 2072–2074, 2001. View at Google Scholar · View at Scopus
  54. N. T. Oran and I. Eser, “Impact of heparin locking frequency on preventing temporary dialysis catheter dysfunction in haemodialysis patients,” Journal of Renal Care, vol. 34, no. 4, pp. 199–202, 2008. View at Publisher · View at Google Scholar · View at Scopus
  55. R. M. Q. Shanks, J. L. Sargent, R. M. Martinez, M. L. Graber, and G. A. O'Toole, “Catheter lock solutions influence staphylococcal biofilm formation on abiotic surfaces,” Nephrology Dialysis Transplantation, vol. 21, no. 8, pp. 2247–2255, 2006. View at Publisher · View at Google Scholar · View at Scopus
  56. S. R. Ash, R. A. Mankus, J. M. Sutton et al., “Concentrated sodium citrate (23%) for catheter lock,” Hemodialysis International, vol. 4, pp. 22–31, 2000. View at Google Scholar
  57. J. E. Moran and S. R. Ash, “Locking solutions for HD catheters: heparin and citrate—a position paper by ASDIN,” Seminars in Dialysis, vol. 21, pp. 490–492, 2008. View at Google Scholar
  58. D. G. Maki, S. R. Ash, R. K. Winger, and P. Lavin, “A novel antimicrobial and antithrombotic lock solution for hemodialysis catheters: a multi-center, controlled, randomized trial,” Critical Care Medicine, vol. 39, pp. 613–620, 2011. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Kethireddy and N. Safdar, “Urokinase lock or flush solution for prevention of bloodstream infections associated with central venous catheters for chemotherapy: a meta-analysis of prospective randomized trials,” Journal of Vascular Access, vol. 9, no. 1, pp. 51–57, 2008. View at Google Scholar · View at Scopus
  60. M. M. Bern, J. J. Lokich, S. R. Wallach et al., “Very low doses of warfarin can prevent thrombosis in central venous catheters. A randomized prospective trial,” Annals of Internal Medicine, vol. 112, no. 6, pp. 423–428, 1990. View at Google Scholar · View at Scopus
  61. M. A. Crowther, C. M. Clase, P. J. Margetts et al., “Low-intensity warfarin is ineffective for the prevention of PTFE graft failure in patients on hemodialysis: a randomized controlled trial,” Journal of the American Society of Nephrology, vol. 13, no. 9, pp. 2331–2337, 2002. View at Publisher · View at Google Scholar · View at Scopus